Literature DB >> 15607935

Treatment of head and neck cancer in elderly patients: state of the art and guidelines.

Daniele Bernardi1, Luigi Barzan, Giovanni Franchin, Roberta Cinelli, Luca Balestreri, Umberto Tirelli, Emanuela Vaccher.   

Abstract

Although the majority of head and neck cancers occur between the fifth and sixth decade, their onset in patients older than 60 years is not a rare event. A peculiar characteristic of almost all case series is the lower prevalence of radical treatments among elderly as compared to younger patients, in particular surgery and combined treatment of surgery plus radiation therapy or chemotherapy and radiation therapy. Radiotherapy is a feasible treatment in elderly patients, also in very advanced age groups and, in the era of organ preservation, chemotherapy combined with RT has a paramount importance. Therapeutical planning must be based not only on tumor characteristics, but also on the physiological, rather than the chronological age the patient. The main clinical problem is, therefore, the selection of patients to be administered anticancer treatment. In patients aged 70 or older, complete geriatric assessment and a multidisciplinary approach are the crucial points.

Entities:  

Mesh:

Year:  2005        PMID: 15607935     DOI: 10.1016/j.critrevonc.2004.08.001

Source DB:  PubMed          Journal:  Crit Rev Oncol Hematol        ISSN: 1040-8428            Impact factor:   6.312


  24 in total

1.  Treatment of head and neck cancer in the elderly: European Consensus (panel 6) at the EUFOS Congress in Vienna 2007.

Authors:  Reidar Grénman; Dominique Chevalier; Vincent Gregoire; Eugene Myers; Simon Rogers
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-05-09       Impact factor: 2.503

2.  Prevalence of bisphosphonate associated osteonecrosis of the jaw within the field of osteonecrosis.

Authors:  Christian Walter; Knut A Grötz; Martin Kunkel; Bilal Al-Nawas
Journal:  Support Care Cancer       Date:  2006-08-29       Impact factor: 3.603

Review 3.  Comorbidity in patients with cancer of the head and neck: prevalence and impact on treatment and prognosis.

Authors:  Jay F Piccirillo; Anna Vlahiotis
Journal:  Curr Oncol Rep       Date:  2006-03       Impact factor: 5.075

4.  Cancer in the elderly.

Authors:  A Hervás Morón
Journal:  Clin Transl Oncol       Date:  2007-10       Impact factor: 3.405

Review 5.  Management of head and neck cancer in elderly patients.

Authors:  Yassine Lalami; Gilberto de Castro; Chantal Bernard-Marty; Ahmad Awada
Journal:  Drugs Aging       Date:  2009       Impact factor: 3.923

6.  Radiotherapy for elderly patients and cetuximab, a monocentric study.

Authors:  Alexander T Falk; Christophe Hébert; Antoine Tran; Marie-Eve Chand; Axel Leysalle; Juliette Thariat; Olivier Dassonville; Gilles Poissonnet; Alexandre Bozec; Esma Saada; Fréderic Peyrade; Karen Benezery
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-10-11       Impact factor: 2.503

7.  Elderly patients with squamous cell carcinoma of the head and neck and the benefit of multimodality therapy.

Authors:  Virginia A Moye; Sindhu Chandramouleeswaran; Ni Zhao; Hyman B Muss; Mark C Weissler; David N Hayes; Jose P Zevallos
Journal:  Oncologist       Date:  2015-01-12

8.  Trends in chemoradiation use in elderly patients with head and neck cancer: Changing treatment patterns with cetuximab.

Authors:  Shrujal S Baxi; Caitriona O'Neill; Eric J Sherman; Coral L Atoria; Nancy Y Lee; David G Pfister; Elena B Elkin
Journal:  Head Neck       Date:  2015-06-26       Impact factor: 3.147

9.  Incidence and risk factors for morbidity and mortality in elderly head and neck cancer patients undergoing major oncological surgery.

Authors:  Shin Hyuk Yoo; Jong-Lyel Roh; Seung-Ho Choi; Soon Yuhl Nam; Sang Yoon Kim
Journal:  J Cancer Res Clin Oncol       Date:  2016-03-16       Impact factor: 4.553

10.  Free flap reconstruction for head and neck cancer can be safely performed in both young and elderly patients after careful patient selection.

Authors:  Thomas T A Peters; Sophie F Post; Boukje A C van Dijk; Jan L N Roodenburg; Bernard F A M van der Laan; Paul M N Werker; Gyorgy B Halmos
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-09-13       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.